|Age:||65 years or older|
|Keywords:||kidney transplant, neurological side effects, memory, tremor, cognition|
|Type:||Drug study, Phase 4|
You will be in this study for 6 weeks. You will either stay on your current anti-rejection medications or it will be changed to include Envarsus ® XR. You will have two additional study visits compared to if you were not to participate in this study.
During these visits we will ask you some questions to assess neurological side effects. These questions will be provided in the form of a written questionaire. These visits will occur at the start of your study participation (Wk 0-1) and at the end of your study participation (Wk 6-8).
These visits will be about one hour each. During these visits you will interact with the study doctor, nurse or coordinator. The research will be conducted at the UC Davis Health campus. Whether or not you choose to participate in this study, you will continue to be followed by your Transplant team with lab draws and clinic appointments as indicated.
If you are placed on Envarsus XR ® and choose to remain on the medication at the of the 6 week study, you may discuss that with your doctor. We may contact you in the future to see if you would be interested in participating long term follow up study for patients on this medication.
The treatment you get will be chosen by chance, like flipping a coin. Neither you nor the study doctor will choose what treatment you get. You will have an equal chance of being given each treatment.
Have any questions or want to learn more? Leave your contact details below and the research team will reach out to you.